-
Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data.
Drug Metab Dispos. 2006 Oct;34(10):1722-33
PMID: 16815965
-
Drug metabolite identification: stable isotope methods.
J Clin Pharmacol. 1986 Jul-Aug;26(6):427-34
PMID: 3734132
-
Metabonomics: a platform for studying drug toxicity and gene function.
Nat Rev Drug Discov. 2002 Feb;1(2):153-61
PMID: 12120097
-
HMDB: the Human Metabolome Database.
Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6
PMID: 17202168
-
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics.
Nat Med. 2002 Dec;8(12):1439-44
PMID: 12447357
-
Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone).
J Pharmacol Exp Ther. 2006 Sep;318(3):1330-42
PMID: 16775196
-
Microbial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets.
J Ind Microbiol Biotechnol. 2005 Jun;32(6):234-52
PMID: 15895265
-
3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.
Drug Metab Dispos. 2006 Sep;34(9):1563-74
PMID: 16782768
-
Plant metabolomics: towards biological function and mechanism.
Trends Plant Sci. 2006 Oct;11(10):508-16
PMID: 16949327
-
Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man.
Drug Metab Dispos. 1975 Sep-Oct;3(5):332-7
PMID: 241613
-
High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics.
Methods Mol Biol. 2007;358:159-74
PMID: 17035686
-
A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse.
Chem Res Toxicol. 2006 Jun;19(6):818-27
PMID: 16780361
-
Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.
Oncogene. 2006 Mar 13;25(11):1629-38
PMID: 16550163
-
Application of chimeric mice with humanized liver for predictive ADME.
Drug Metab Rev. 2007;39(1):145-57
PMID: 17364883
-
A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.
Chem Res Toxicol. 2007 Mar;20(3):531-42
PMID: 17279779
-
Metabolism of debrisoquine sulphate in rat, dog and man.
Xenobiotica. 1976 Jul;6(7):405-9
PMID: 997588
-
The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?
Philos Trans R Soc Lond B Biol Sci. 2006 Jan 29;361(1465):147-61
PMID: 16553314
-
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.
Nature. 1988 Feb 4;331(6155):442-6
PMID: 3123997
-
Normalization method for metabolomics data using optimal selection of multiple internal standards.
BMC Bioinformatics. 2007;8:93
PMID: 17362505
-
Metabolite profiling: from diagnostics to systems biology.
Nat Rev Mol Cell Biol. 2004 Sep;5(9):763-9
PMID: 15340383
-
Cytochrome P450 and xenobiotic receptor humanized mice.
Annu Rev Pharmacol Toxicol. 2006;46:41-64
PMID: 16402898
-
Pharmaco-metabonomic phenotyping and personalized drug treatment.
Nature. 2006 Apr 20;440(7087):1073-7
PMID: 16625200
-
1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humans.
Drug Metab Dispos. 1998 Nov;26(11):1096-101
PMID: 9806952
-
When good drugs go bad.
Nature. 2007 Apr 26;446(7139):975-7
PMID: 17460642
-
The fate of acetanilide in man.
J Pharmacol Exp Ther. 1948 Sep;94(1):29-38
PMID: 18885611
-
Pharmacogenomics: translating functional genomics into rational therapeutics.
Science. 1999 Oct 15;286(5439):487-91
PMID: 10521338
-
Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.
Pharmacogenomics. 2006 Oct;7(7):1055-75
PMID: 17054416
-
High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies.
J Proteome Res. 2005 Mar-Apr;4(2):591-8
PMID: 15822939
-
Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism.
Nat Rev Drug Discov. 2003 Aug;2(8):668-76
PMID: 12904817
-
Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics.
Anal Bioanal Chem. 2007 Jan;387(2):525-7
PMID: 16955259
-
Computational prediction of human drug metabolism.
Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):303-24
PMID: 16922645
-
The metabolomics of (+/-)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases.
Biochem Pharmacol. 2007 Feb 15;73(4):561-73
PMID: 17123469
-
Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis.
Rapid Commun Mass Spectrom. 2005;19(18):2659-70
PMID: 16124034
-
Hypotensive response to debrisoquine and hydroxylation phenotype.
Life Sci. 1978 Mar;22(11):979-83
PMID: 642709
-
Role of gene knockout and transgenic mice in the study of xenobiotic metabolism.
Drug Metab Rev. 2003 Nov;35(4):319-35
PMID: 14705864
-
Data processing for mass spectrometry-based metabolomics.
J Chromatogr A. 2007 Jul 27;1158(1-2):318-28
PMID: 17466315
-
Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids.
Rapid Commun Mass Spectrom. 2003;17(23):2632-8
PMID: 14648901
-
Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.
Cancer Res. 2000 Dec 15;60(24):6921-6
PMID: 11156391
-
Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation.
Drug Metab Dispos. 1993 May-Jun;21(3):403-9
PMID: 8100494
-
Polymorphic hydroxylation of Debrisoquine in man.
Lancet. 1977 Sep 17;2(8038):584-6
PMID: 71400
-
Cytochrome P450 humanised mice.
Hum Genomics. 2004 May;1(4):300-6
PMID: 15588489
-
Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
J Biol Chem. 2003 Apr 11;278(15):13480-6
PMID: 12566435
-
Stable isotope labeling of Arabidopsis thaliana for an NMR-based metabolomics approach.
Plant Cell Physiol. 2004 Aug;45(8):1099-104
PMID: 15356336
-
Drug metabolism and drug interactions: application and clinical value of in vitro models.
Curr Drug Metab. 2003 Oct;4(5):423-59
PMID: 14529374
-
Achievement of a 920-MHz high resolution NMR.
J Magn Reson. 2002 Jun;156(2):318-21
PMID: 12165269
-
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.
Trends Pharmacol Sci. 2006 Nov;27(11):580-6
PMID: 17005258
-
Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.
Chem Res Toxicol. 2001 Jun;14(6):611-50
PMID: 11409933
-
From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.
J Proteome Res. 2007 Feb;6(2):459-68
PMID: 17269703
-
Chemometrics in metabonomics.
J Proteome Res. 2007 Feb;6(2):469-79
PMID: 17269704
-
Mass spectrometry-based metabolomics.
Mass Spectrom Rev. 2007 Jan-Feb;26(1):51-78
PMID: 16921475
-
Near completely humanized liver in mice shows human-type metabolic responses to drugs.
Am J Pathol. 2004 Sep;165(3):901-12
PMID: 15331414
-
The metabolism of [14C]-debrisoquine in man.
Br J Clin Pharmacol. 1979 Mar;7(3):257-66
PMID: 371651